Amelia Jones |
HEOR is proud to be exhibiting and presenting at the upcoming World Orphan Drug Congress in Amsterdam on 27-29 October. This is a fantastic opportunity to be at the forefront of conversations driving the future of rare disease treatment and access – from cutting-edge research and evolving policy landscapes to breakthrough innovations transforming patient outcomes.
Jen Lee, Principal Portfolio Consultant at HEOR, will host a session on ‘Solving the rare disease puzzle through thought partnership’ alongside Miranda Bailey, Associate Vice President, HEOR & Pricing at Rocket Pharmaceuticals, Inc. The session will delve into the concept of thought partnership between industry and consultancy, exploring how strategic collaboration can help navigate the complex HEOR and market access landscape for rare disease assets. Jen and Miranda will also define what true thought partnership means, examine the unique evidence and access challenges in rare diseases, and demonstrate how a collaborative approach can lead to meaningful outcomes for both patients and stakeholders. Learn more about their session: World Orphan Drug Congress Europe 2025 | Agenda
HEOR will also be exhibiting – visit booth 10.111 to connect with Jen and other experts from HEOR, Ewa Stawowczyk and Owen Daykin-Pont. They are looking forward to discussing your challenges and strategic solutions shaping success in the rare disease space.